Karla Viviani Allebrandt

Dr. Karla Allebrandt is a Global Senior Manager and Senior Expert at Boehringer Ingelheim, working at the intersection of medical excellence, digital health, and strategic partnerships to accelerate the adoption of innovative technologies across the R&D lifecycle. She combines end‑to‑end expertise spanning translational medicine, multimodal data integration, and digital biomarker strategy, enabling the practical application of AI and data science to improve patient‑centric study design and evidence generation. Her work advances cross‑sector collaboration between pharma, academia, and healthcare systems, equipping teams with the capabilities and know‑how to integrate real‑world data and digital health solutions into clinical development. She represents Boehringer Ingelheim in the EFPIA Digital Health Working Group, contributing to European policy and frameworks for digital innovation. Previously, she served as Translational Lead and Director of External Collaborations in CNS at Boehringer Ingelheim, advancing early clinical programs, biomarker strategies, and large‑scale academic partnerships. Earlier at Sanofi, she led data‑driven strategies for biomarker discovery and patient stratification in cardiometabolic diseases. Her academic background is rooted in genetics and neurogenetics, complemented by her role as Privatdozent (Adjunct Professor) in Medical Psychology at LMU Munich, where she has led multicenter genomic and digital health research.